Company intelligence
AG Mednet, Inc.
Welcome to the clinical trials revolution
Biotechnology Research
Boston, US
79 employees
Founded 2004
3 public signals
About AG Mednet, Inc.
Judi by AG Mednet empowers the doers, clinical trial leaders, and medical innovators, with streamlined process management software, allowing them to focus on what they do best, providing breakthrough treatments and products. We remove unnecessary cost and effort, introducing greater control, enabling transparency, and allowing seamless collaboration, which speeds the time to market.
Verified activity
Signals from AG Mednet, Inc.
3 published signals
Legal & Regulatory
AG Mednet, Inc. secured FDA Fast Track designation for ERAS-0015, an investigational pan-RAS molecular glue targeted at patients with metastatic pancreatic adenocarcinoma.
Reported by Ricardo Valdes
Partnerships
AG Mednet, Inc. notes that Eli Lilly established a strategic collaboration with Amplitude Therapeutics to harness advanced generative AI models for drug discovery.
Reported by Ricardo Valdes
Legal & Regulatory
AG Mednet, Inc. was informed that the U.S. Food and Drug Administration (FDA) finalized its guidance regarding formal sponsor meetings under the Prescription Drug User Fee Act (PDUFA) VII, replacing the previous draft issued in late 2023.
Reported by Ricardo Valdes